Avalon Advanced Materials Inc. to Participate in UBS Global Materials Conference
Toronto, Ontario–(Newsfile Corp. – August 11, 2026) – Avalon Advanced Materials Inc. (TSX: AVL) (OTCQB: AVLNF) (“Avalon” or the “Company”)…
Vale and ABB form strategic alliance to accelerate digital transformation in iron ore operations in Brazil
Carlos Medeiros, Vale’s Vice President of Operations, and Joachim Braun, President of ABB’s Process Industries Division, sign the agreement for…
Swiss Re reports $2.8bn first-half net income, remains on track for 2026 targets
Swiss Re reported that its second-quarter net income for 2026 reached $1.3bn, bringing its first-half net income to…
Swiss Luxury Skincare Brand BILATTE Expands into France’s Premium Beauty Retail Market, Launching Global Offline Growth Strategy and Opening Traceability Experiences Worldwide
Road Town, British Virgin Islands, July 28, 2026 — BILATTE, a prestigious medical skincare brand originating from the…
PharmaBlock Convenes Global Industry Leaders in Zurich to Advance Green Chemistry for Sustainable Pharmaceutical Manufacturing
ZURICH, July 20, 2026 /PRNewswire/ — As Europe experienced one of its hottest Junes on record, with prolonged…
Switzerland tops the European Innovation Scoreboard once again
Europe’s innovation performance continues to improve, with the EU’s overall score rising by 11.6 percentage points since 2019,…
AI investment offsets geopolitical risks for Asia, says Swiss Re
Asian insurers and the global insurance industry continue to suffer disruptive supply shocks and barriers to the free…
Swiss International University strengthens global standin…
Swiss International University SIU has reached an important global milestone by landing a spot among the world top…
Global: Swiss Re’s transition from climate leader to laggard
World’s largest reinsurers are taking increasingly different approaches to fossil fuel expansion, according to a new briefing published…
AstraZeneca and Roche battle for a cancer breakthrough
While the weight-loss market has generally consumed pharmaceutical investors’ attention over the past couple of years, other areas…
Roche announces global collaboration with Nurix Therapeutics to co-develop and co-commercialise potential best-in-class BTK degrader bexobrutideg across malignant haematology, immunology and neurology
Agreement offers potential best-in-class targeted protein degrader therapy option for people living with B-cell malignanciesCollaboration adds to Roche’s…
Alternative Ballistics Corporation (OTCQB: ALBC) Receives Swiss Academy Award for Global Impact Through its Chairperson Vanessa Luna
International recognition highlights Alternative Ballistics’ leadership in next-generation less-lethal public safety technologies Supports the Company’s expanding commercial opportunities…